Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDillistone Regulatory News (DSG)

Share Price Information for Dillistone (DSG)

Share Price is delayed by 15 minutes
Get Live Data
11.50    0.00 (0.00%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £4.07m
DSG Live PriceLast checked at - London Stock Exchange

Intraday Dillistone Share Chart

Directorate Change

16 Feb 2010 16:46

RNS Number : 2441H
Dillistone Group PLC
16 February 2010
 



Dillistone Group Plc

 

Directorate Change

 

Dillistone Group Plc ("Dillistone" or the "Company"), the AIM listed supplier of recruitment software, announces that, Jim McLaughlin has resigned from his position as Executive Chairman and Finance Director with immediate effect.

The Board would like to thank Jim McLaughlin for his valuable contribution to the Company and wish him well in his future endeavours.

The Board would like to reassure shareholders that the Board's ongoing strategy for Dillistone will remain unchanged and that, in line with the pre-close trading update made on 18 January 2010, the Company continues to trade in line with market expectations and will be paying the further interim dividend in respect of the year ended 31 December 2009 amounting to 7 pence per share, on 1 April 2010 to holders on the register on 5 March 2010.

 

Dr. Mike Love, Non-Executive Director, has assumed the role of Non-Executive Chairman. Jason Starr, Managing Director of Dillistone commented;

 

"The Board is delighted that Dr. Mike Love has accepted the role of Non-Executive Chairman. Mike Love is an experienced AIM director. In addition to his role at Dillistone he is also executive chairman of SciSys plc and chairman of ClearStream Technologies Group plc both of which are AIM quoted companies. He is also a former member of the AIM Advisory Group of the London Stock Exchange."

 

The Board is currently reviewing its options in relation to appointing a new Finance Director and will inform shareholders as soon as a suitable candidate has been appointed.

 

Following the departure of Jim McLaughlin and pending the appointment of the new Finance Director, the Audit, Remuneration and Nomination committees will comprise Dr. Mike Love and Jason Starr.

 

The Board continues to expect to announce Dillistone's preliminary results for the year ended 31 December 2009 on 1 April 2010.

 

Enquiries:

 

Mike Love, Chairman Dillistone Group Plc

01749 870 940

Emily Staples, Blomfield Corporate Finance Limited

0207 444 0800

Daniel Briggs, Religare Hichens, Harrison

0207 444 0500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUACPUPUGQQ
Date   Source Headline
7th May 20267:00 amRNSFinal Results & Investor Presentation
24th Apr 20267:00 amRNSNotice of Final Results & Investor Presentation
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:44 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
9th Mar 20262:23 pmRNSHolding(s) in Company
2nd Mar 20263:08 pmRNSHolding(s) in Company
25th Feb 202611:40 amRNSHolding(s) in Company
25th Feb 202610:09 amRNSHolding(s) in Company
23rd Feb 20262:28 pmRNSResult of GM & Directorate Change
11th Feb 202612:59 pmRNSHolding(s) in Company
5th Feb 202611:28 amRNSResult of Placing and Subscription
4th Feb 20264:47 pmRNSProposed Placing and Subscription
30th Sep 20257:00 amRNSInterim Results & Investor Presentation
11th Sep 20257:00 amRNSNotice of Interim Results & Investor Presentation
4th Jun 202511:50 amRNSResult of AGM
4th Jun 20257:01 amRNSAGM Statement
4th Jun 20257:00 amRNSRelated party loan
9th May 202511:32 amRNSDirectorate Declaration
8th Apr 20257:00 amRNSFinal Results & Investor Presentation
3rd Apr 20257:00 amRNSNotice of Results & Investor Presentation
5th Feb 20257:00 amRNSTrading Update & Notice of Results
4th Dec 20247:00 amRNS-ROpenAI powered Interview Simulation Platform
17th Sep 20247:00 amRNSInterim Results & Investor Presentation
11th Sep 20247:00 amRNSNotice of Results & Investor Presentation
2nd Sep 20249:45 amRNSHolding(s) in Company
29th Aug 20248:30 amRNSHolding(s) in Company
23rd Aug 20247:00 amRNSTrading update and Fund Raising
15th Jul 20247:00 amRNSChange of Adviser
12th Jun 20241:40 pmRNSResult of AGM
12th Jun 20247:00 amRNSAGM Statement
25th Apr 20247:00 amRNSFinal Results & Investor Presentation
22nd Apr 20247:00 amRNSNotice of Results & Investor Presentation
9th Apr 20247:00 amRNSBlock listing Interim Review
30th Jan 20247:00 amRNSTrading Update & Notice of Results
9th Oct 20237:00 amRNSBlock listing Interim Review
26th Sep 20237:00 amRNSInterim Results & Investor Presentations
18th Sep 20237:00 amRNSNotice of Results & Investor Presentations
13th Jun 20231:18 pmRNSResult of AGM
13th Jun 20237:00 amRNSAGM Statement
25th Apr 20237:00 amRNSFinal Results & Investor Presentation
11th Apr 20237:00 amRNSBlock listing Interim Review
30th Mar 20237:00 amRNSContract & Notice of Results
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
7th Nov 20227:00 amRNSDirector Dealings
10th Oct 20227:00 amRNSBlock listing Interim Review
26th Sep 20227:01 amRNSDirectorate Changes
26th Sep 20227:00 amRNSInterim Results & Investor Presentation
20th Sep 20227:00 amRNSNotice of Results & Investor Presentation
16th Jun 20228:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.